115 related articles for article (PubMed ID: 23891094)
1. Inhibiting the phosphatidylinositide 3-kinase pathway blocks radiation-induced metastasis associated with Rho-GTPase and Hypoxia-inducible factor-1 activity.
Burrows N; Telfer B; Brabant G; Williams KJ
Radiother Oncol; 2013 Sep; 108(3):548-53. PubMed ID: 23891094
[TBL] [Abstract][Full Text] [Related]
2. GDC-0941 inhibits metastatic characteristics of thyroid carcinomas by targeting both the phosphoinositide-3 kinase (PI3K) and hypoxia-inducible factor-1α (HIF-1α) pathways.
Burrows N; Babur M; Resch J; Ridsdale S; Mejin M; Rowling EJ; Brabant G; Williams KJ
J Clin Endocrinol Metab; 2011 Dec; 96(12):E1934-43. PubMed ID: 21994956
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas.
Burrows N; Williams J; Telfer BA; Resch J; Valentine HR; Fitzmaurice RJ; Eustace A; Irlam J; Rowling EJ; Hoang-Vu C; West CM; Brabant G; Williams KJ
Oncotarget; 2016 Sep; 7(39):63106-63123. PubMed ID: 27527858
[TBL] [Abstract][Full Text] [Related]
4. Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas.
Burrows N; Resch J; Cowen RL; von Wasielewski R; Hoang-Vu C; West CM; Williams KJ; Brabant G
Endocr Relat Cancer; 2010 Mar; 17(1):61-72. PubMed ID: 19808899
[TBL] [Abstract][Full Text] [Related]
5. [18F]-FLT positron emission tomography can be used to image the response of sensitive tumors to PI3-kinase inhibition with the novel agent GDC-0941.
Cawthorne C; Burrows N; Gieling RG; Morrow CJ; Forster D; Gregory J; Radigois M; Smigova A; Babur M; Simpson K; Hodgkinson C; Brown G; McMahon A; Dive C; Hiscock D; Wilson I; Williams KJ
Mol Cancer Ther; 2013 May; 12(5):819-28. PubMed ID: 23427298
[TBL] [Abstract][Full Text] [Related]
6. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3'-kinase signaling pathway is essential for Rac1-induced hypoxia-inducible factor-1(alpha) and vascular endothelial growth factor expression.
Xue Y; Li NL; Yang JY; Chen Y; Yang LL; Liu WC
Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2169-76. PubMed ID: 21357506
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1.
Jiang BH; Jiang G; Zheng JZ; Lu Z; Hunter T; Vogt PK
Cell Growth Differ; 2001 Jul; 12(7):363-9. PubMed ID: 11457733
[TBL] [Abstract][Full Text] [Related]
9. Macrophages confer resistance to PI3K inhibitor GDC-0941 in breast cancer through the activation of NF-κB signaling.
Usman MW; Gao J; Zheng T; Rui C; Li T; Bian X; Cheng H; Liu P; Luo F
Cell Death Dis; 2018 Jul; 9(8):809. PubMed ID: 30042442
[TBL] [Abstract][Full Text] [Related]
10. Distinct role of phosphatidylinositol 3-kinase and Rho family GTPases in Vav3-induced cell transformation, cell motility, and morphological changes.
Sachdev P; Zeng L; Wang LH
J Biol Chem; 2002 May; 277(20):17638-48. PubMed ID: 11884391
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-11 promotes epithelial-mesenchymal transition in anaplastic thyroid carcinoma cells through PI3K/Akt/GSK3β signaling pathway activation.
Zhong Z; Hu Z; Jiang Y; Sun R; Chen X; Chu H; Zeng M; Sun C
Oncotarget; 2016 Sep; 7(37):59652-59663. PubMed ID: 27487122
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
Gong T; Cui L; Wang H; Wang H; Han N
J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
[TBL] [Abstract][Full Text] [Related]
13. Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941.
Raynaud FI; Eccles SA; Patel S; Alix S; Box G; Chuckowree I; Folkes A; Gowan S; De Haven Brandon A; Di Stefano F; Hayes A; Henley AT; Lensun L; Pergl-Wilson G; Robson A; Saghir N; Zhyvoloup A; McDonald E; Sheldrake P; Shuttleworth S; Valenti M; Wan NC; Clarke PA; Workman P
Mol Cancer Ther; 2009 Jul; 8(7):1725-38. PubMed ID: 19584227
[TBL] [Abstract][Full Text] [Related]
14. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z
Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938
[TBL] [Abstract][Full Text] [Related]
15. UVB radiation induces expression of HIF-1alpha and VEGF through the EGFR/PI3K/DEC1 pathway.
Li Y; Bi Z; Yan B; Wan Y
Int J Mol Med; 2006 Oct; 18(4):713-9. PubMed ID: 16964427
[TBL] [Abstract][Full Text] [Related]
16. Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways.
Zhang Q; Tang X; Zhang ZF; Velikina R; Shi S; Le AD
Clin Cancer Res; 2007 Aug; 13(16):4686-94. PubMed ID: 17699846
[TBL] [Abstract][Full Text] [Related]
17. PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation.
Zhou J; Schmid T; Frank R; Brüne B
J Biol Chem; 2004 Apr; 279(14):13506-13. PubMed ID: 14726529
[TBL] [Abstract][Full Text] [Related]
18. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines.
Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q
Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia enhances the migration and invasion of human glioblastoma U87 cells through PI3K/Akt/mTOR/HIF-1α pathway.
Huang W; Ding X; Ye H; Wang J; Shao J; Huang T
Neuroreport; 2018 Dec; 29(18):1578-1585. PubMed ID: 30371540
[TBL] [Abstract][Full Text] [Related]
20. PI3K and RAC signalling in leukocyte and cancer cell migration.
Barber MA; Welch HC
Bull Cancer; 2006 May; 93(5):E44-52. PubMed ID: 16777617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
